[Cys]-Influenza Virus Nucleoprotein (311 – 325) – Antimicrobial Peptides – AMP

The Influenza Virus Nucleoprotein (311 – 325) is a component of the viral ribonucleotide complex, derived from the influenza virus and it is involved in viral replication, RNA packing and nuclear trafficking. As a monomer it contains basic residues which allow it to bind to single stranded RNA and through its flexible tail loop it has the ability to form NP oligomers. Furthermore NP is able to support the viral polymerase structurally, through associating with the two subunits PB1 and PB2, and it allows the viral ribonucleotide complex to be transported in and out of the nucleus due to its nuclear localisation and nuclear export signals. During influenza viral replication messenger RNA, viral genome RNA and complementary positive-sense RNA are produced and NP is crucial for this replication. Inhibitors of NP have potential to be used to prevent the influenza virus in humans.

 

Technical specification

 KD20 peptide Sequence : H-CQVYSLIRPNENPAHK-OH
 KD20 peptide MW : 1.867.9 g/mol
 KD20 peptide Purity : > 95%
 KD20 peptide Counter-Ion : TFA Salts
Peptide library synthesis KD20 peptide Delivery format : Lyophilized

Price

 

Product Size Price €
Price $
CRB1000693-0.5 mg 0.5 mg 141 € 113 $
CRB1000693-1 mg 1 mg 193 € 154 $
CRB1000693-5 mg 5 mg 519 € 415 $
CRB1000693-
CRB1000693-

For Bulk Orders